Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer

Emerging proof shows that abnormal lipometabolism affects invasion, metastasis, stemness and tumor microenvironment in carcinoma cells. However, molecular markers related to lipometabolism have not been further established in breast cancer. In addition, numerous studies have been conducted to screen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lei, She, Risheng, Zhu, Jianlin, Lu, Jin, Gao, Yuan, Song, Wenhua, Cai, Songwang, Wang, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526348/
https://www.ncbi.nlm.nih.gov/pubmed/36182903
http://dx.doi.org/10.1186/s12885-022-10110-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526348/
https://www.ncbi.nlm.nih.gov/pubmed/36182903
http://dx.doi.org/10.1186/s12885-022-10110-8

Ejemplares similares